Shares of pSivida Corp. (NASDAQ:PSDV) were up 6.7% on Thursday . The company traded as high as $3.64 and last traded at $3.48, with a volume of 425,912 shares. The stock had previously closed at $3.26.

Separately, FBR & Co reiterated a “buy” rating and set a $7.00 price target (up from $6.00) on shares of pSivida Corp. in a research report on Thursday, May 12th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the company’s stock. pSivida Corp. has an average rating of “Hold” and a consensus price target of $7.00.

The firm has a 50 day moving average price of $3.21 and a 200 day moving average price of $3.16. The company’s market cap is $119.60 million.

pSivida Corp. (NASDAQ:PSDV) last posted its earnings results on Thursday, May 5th. The company reported ($0.15) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.20) by $0.05. On average, equities analysts predict that pSivida Corp. will post ($0.62) earnings per share for the current fiscal year.

pSivida Corp. is a biotechnology company, which is engaged in the development of sustained-release drug-delivery products for treating eye diseases. The Company offers products for treatment of back-of-the-eye diseases. The Company’s lead development product, Medidur is used for posterior of the eye (posterior uveitis).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.